ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Femtech Market Size to Reach Revenues of around USD 75.74 Billion by 2026 – Arizton

The global femtech market size to reach around USD 75.74 billion by 2026, growing at a CAGR of over 13.32% during the forecast period.

CHICAGO, ILLINOIS, UNITED STATES, June 30, 2021 /EINPresswire.com/ -- In-depth analysis and data-driven insights on the impact of COVID-19 included in this global femtech market report.

The femtech market is expected to grow at a CAGR of over 13.32% during the period 2020−2026.

Key Highlights Offered in the Report:
1. The global femetch market is likely to have a steady growth rate and is anticipated to witness incremental and absolute growth of around USD 40 billion and approximately 112% respectively, during the forecast period.
2. The device segment accounted for the highest share and the software segment is likely to grow with a CAGR of around 15% during the forecast period.
3. The menstrual health segment accounted for the largest share and the fertility segment is anticipated to witness the highest CAGR of over 14% during the forecast period.
4. The treatment segment accounted for the highest share and the general wellness segment is expected to grow with a CAGR of around 16% during the forecast period.
5. North America dominated with the highest share while APAC is expected to grow with a CAGR of over 15% during the forecast period.

Key Offerings:
• Market Size & Forecast by Revenue | 2020−2026
• Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities
• Market Segmentation – A detailed analysis by product type, indication, application, end-user, and geography
• Competitive Landscape – 40 vendors are profiled in this report

Get your sample today!

Femtech Market – Segmentation

• The demand for smart medical devices with more comfort and reduced side effects is gaining traction in female-focused health products. Femtech investors, fitness wearable manufacturers, and health advocates should focus on creating solutions for the entire spectrum of women.
• Femtech assists women through pre-pregnancy, pregnancy to the post-pregnancy stage. Latest technology solutions can help with newborn baby health monitoring and nursing care. Many startups are creating innovative digital technologies incorporated into the femtech products, thereby driving the market's growth.
• Technological advancements can keep women informed about their health issues and be managed efficiently. Diagnostic and screening services are mostly performed by using medical devices specific for diagnosing female health conditions. Endodiag, a French medical technology company that allows early diagnosis of endometriosis, and iSono Health developed a screening device for breast cancer.

• Segmentation by Product Type
• Device
• Software
• Segmentation by Indication
• Maternal Health
• Fertility
• Menstruation
• Sexual Wellness
• Others
• Segmentation by Application
• Treatment
• Diagnosis
• General Wellness
• Segmentation by End-user
• Hospitals & Surgical Centers
• Diagnostic Centers
• Fertility Clinics
• Direct to Consumer

Femtech Market – Dynamics

In recent years, various technological advancements have paved the way for balancing gender inequalities. This, in turn, has led to the introduction of several female-centric health products that is utilizing technology to support women’s health and overall wellness. As sensor technology continues to advance and materials are becoming increasingly sophisticated, they can be used in a range of wearables that can particularly aid in pregnancy and family planning. Likewise, various tools are being developed as a part of growing collaboration in the femtech industry. Areas that are currently covered in the industry include menstruation, pregnancy, fertility, sex, and reproduction. Femtech is completely dependent on digital technology. Tools available in the industry include wearable medical devices, internet-connected medical devices, and mobile applications.

Key Drivers and Trends fueling Market Growth:
• Growing Interest of Venture Capitalists
• Inclusive Care for Queer Communities through Femtech
• Increasing Demand for Digital Health Solutions
• Large Growth Potential in Femtech Services
Femtech Market – Geography

North America accounted for the largest share in the global femtech market due to increase in female-specific chronic and infectious diseases that potentially raised the need for better diagnosis and treatment solutions developed by leveraging digital technologies. Development contributions by women and growing female health education is influencing the development of technologically innovative solutions. In addition, favorable policies that promote the health and well-being of women is enhancing the development of digital heath solutions in North America. During the forecast period, the US and Canada are the major countries that will contribute to the steady growth of the femtech market in North America.

Get your sample today! https://www.arizton.com/market-reports/femtech-market-size

Segmentation by Geography
• North America
• US
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• APAC
• China
• Japan
• India
• Australia
• South Korea
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• Turkey

Major Vendors
• ALYK
• Aspivix
• Athena Feminine Technologies
• Ava Science
• Biowink GmbH
• Bloomer Tech
• Bloomlife
• Bonzun IVF
• Calla Lily Personal Care
• Cocorointim SL
• Cirqle Biomedical
• Daye
• Elvie
• Emjoy
• FemCy
• Fizimed
• Flo Health
• Freda
• Glow
• Grace Health
• HeraMED
• Inne
• iSono Health
• Joylux
• Juno Bio
• Kasha
• LactApp
• Minerva Surgical
• Moody Month
• Natural Cycles
• Nurx
• NUVO
• NVision Medical
• Peanut
• Tempdrop
• Thinx
• Totohealth
• Univfy
• Willow
• WOOM

Looking for more information? Click Here

Jessica
Arizton Advisory and Inteligence
+1 312-235-2040
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.